TG THERAPEUTICS INC (TGTX:NASDAQ)
$54.87 -0.88 (-1.5785%)
Analysed TG THERAPEUTICS INC (TGTX:NASDAQ) News Sources
TGTX Stock Rises On Wall Street Price Target Hike, New Schizophrenia Trial Launch
07-07-2026
stocktwits.com
Is TG Therapeutics (TGTX) Fully Valued Following Its Schizophrenia Trial Update?
08-07-2026
yahoo.com
Can TG Therapeutics' (TGTX) Schizophrenia Trial Meaningfully Redefine BRIUMVI’s Role Beyond Multiple Sclerosis?
08-07-2026
yahoo.com
2 Fast-Growing Pharmaceutical Stocks to Buy Now
09-07-2026
fool.com
TG Therapeutics (TGTX) Stock May Still Be Cheap Despite New Trial News
09-07-2026
yahoo.com
TG Therapeutics (TGTX) Starts Phase 2 Briumvi Trial
09-07-2026
yahoo.com
TG Therapeutics (TGTX) Gains as Its Key Drug Exceeded Expectations
13-07-2026
yahoo.com
How Roche Unexpectedly Buoyed IBD Stock Of The Day TG Therapeutics
24-07-2026
yahoo.com
TG Therapeutics (TGTX) to Report Q2 Results: Wall Street Expects Earnings Growth
27-07-2026
yahoo.com
Earnings Preview: Amgen (AMGN) Q2 Earnings Expected to Decline
28-07-2026
yahoo.com
What is the current price of TG THERAPEUTICS INC (TGTX:NASDAQ)?
The current price of TG THERAPEUTICS INC (TGTX:NASDAQ) is $54.87.
TG THERAPEUTICS INC (TGTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of TG THERAPEUTICS INC (TGTX:NASDAQ) since the previous trading day is $-0.88.
TG THERAPEUTICS INC (TGTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of TG THERAPEUTICS INC (TGTX:NASDAQ) since the previous trading day is -1.5785%.
What is the most recent average sentiment score for TG THERAPEUTICS INC (TGTX:NASDAQ)?
The most recent average sentiment score for TG THERAPEUTICS INC (TGTX:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for TG THERAPEUTICS INC (TGTX:NASDAQ)?
The most recent sentiment for TG THERAPEUTICS INC (TGTX:NASDAQ) is .
SEC-8K** Filing Available For TG THERAPEUTICS INC (TGTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.